Jazz Pharmaceuticals, an Ireland-based biopharmaceutical company, and other defendants were hit with an antitrust lawsuit Friday in California Northern District Court. The court action claims that the defendants engaged in a scheme to restrain competition for the narcolepsy treatment Xyrem and its generic bioequivalents in the United States. The complaint was brought by Schneider Wallace Cottrell Konecky; and Lowey Dannenberg P.C. on behalf of Molina Healthcare, a health care management business offering services through government programs. Counsel have not yet appeared for the defendants. The case is 3:21-cv-07935, Molina Healthcare Inc. v. Jazz Pharmaceuticals, Inc. et al.